S&P 500   4,960.70 (-0.30%)
DOW   38,489.57 (-0.19%)
QQQ   423.61 (-0.87%)
AAPL   181.59 (+0.02%)
MSFT   399.43 (-0.83%)
META   466.61 (-0.98%)
GOOGL   142.22 (+0.78%)
AMZN   167.65 (+0.34%)
TSLA   193.06 (-0.36%)
NVDA   670.39 (-3.47%)
NIO   6.03 (+1.17%)
AMD   162.50 (-1.93%)
BABA   75.76 (+3.58%)
T   16.98 (+0.41%)
F   12.13 (-0.98%)
MU   80.23 (-0.59%)
CGC   3.34 (-5.65%)
GE   148.30 (-0.22%)
DIS   107.82 (-1.48%)
AMC   4.60 (-1.29%)
PFE   27.54 (-0.18%)
PYPL   57.83 (-1.36%)
XOM   104.37 (+1.58%)
S&P 500   4,960.70 (-0.30%)
DOW   38,489.57 (-0.19%)
QQQ   423.61 (-0.87%)
AAPL   181.59 (+0.02%)
MSFT   399.43 (-0.83%)
META   466.61 (-0.98%)
GOOGL   142.22 (+0.78%)
AMZN   167.65 (+0.34%)
TSLA   193.06 (-0.36%)
NVDA   670.39 (-3.47%)
NIO   6.03 (+1.17%)
AMD   162.50 (-1.93%)
BABA   75.76 (+3.58%)
T   16.98 (+0.41%)
F   12.13 (-0.98%)
MU   80.23 (-0.59%)
CGC   3.34 (-5.65%)
GE   148.30 (-0.22%)
DIS   107.82 (-1.48%)
AMC   4.60 (-1.29%)
PFE   27.54 (-0.18%)
PYPL   57.83 (-1.36%)
XOM   104.37 (+1.58%)
S&P 500   4,960.70 (-0.30%)
DOW   38,489.57 (-0.19%)
QQQ   423.61 (-0.87%)
AAPL   181.59 (+0.02%)
MSFT   399.43 (-0.83%)
META   466.61 (-0.98%)
GOOGL   142.22 (+0.78%)
AMZN   167.65 (+0.34%)
TSLA   193.06 (-0.36%)
NVDA   670.39 (-3.47%)
NIO   6.03 (+1.17%)
AMD   162.50 (-1.93%)
BABA   75.76 (+3.58%)
T   16.98 (+0.41%)
F   12.13 (-0.98%)
MU   80.23 (-0.59%)
CGC   3.34 (-5.65%)
GE   148.30 (-0.22%)
DIS   107.82 (-1.48%)
AMC   4.60 (-1.29%)
PFE   27.54 (-0.18%)
PYPL   57.83 (-1.36%)
XOM   104.37 (+1.58%)
S&P 500   4,960.70 (-0.30%)
DOW   38,489.57 (-0.19%)
QQQ   423.61 (-0.87%)
AAPL   181.59 (+0.02%)
MSFT   399.43 (-0.83%)
META   466.61 (-0.98%)
GOOGL   142.22 (+0.78%)
AMZN   167.65 (+0.34%)
TSLA   193.06 (-0.36%)
NVDA   670.39 (-3.47%)
NIO   6.03 (+1.17%)
AMD   162.50 (-1.93%)
BABA   75.76 (+3.58%)
T   16.98 (+0.41%)
F   12.13 (-0.98%)
MU   80.23 (-0.59%)
CGC   3.34 (-5.65%)
GE   148.30 (-0.22%)
DIS   107.82 (-1.48%)
AMC   4.60 (-1.29%)
PFE   27.54 (-0.18%)
PYPL   57.83 (-1.36%)
XOM   104.37 (+1.58%)

CureVac (CVAC) Earnings Date, Estimates & Call Transcripts

$3.42
-0.05 (-1.44%)
(As of 12:13 PM ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 23Estimated
Actual EPS
(Nov. 14)
-$0.24 Beat By $0.02
Consensus EPS
(Nov. 14)
-$0.26
Skip Charts & View Estimated and Actual Earnings Data

CVAC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CVAC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CureVac Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.91) EPS
Next Year EPS Consensus Estimate: ($0.76) EPS

CVAC Earnings Date and Information

CureVac last released its quarterly earnings data on November 14th, 2023. The reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.26) by $0.02. The business earned $17.94 million during the quarter, compared to the consensus estimate of $15.01 million. CureVac has generated $0.00 earnings per share over the last year. Earnings for CureVac are expected to grow in the coming year, from ($0.91) to ($0.76) per share. CureVac has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 23rd, 2024 based off prior year's report dates.

CureVac Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/23/2024
Estimated)
------- 
11/14/2023Q3 2023($0.26)($0.24)+$0.02($0.24)$15.01 million$17.94 million    
8/17/2023Q2 2023($0.28)($0.33)($0.05)($0.33)$14.89 million$8.25 million
5/30/2023Q1 2023($0.29)($0.29)-($0.29)$16.45 million$7.65 million












CureVac Earnings - Frequently Asked Questions

When is CureVac's earnings date?

CureVac has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 23rd, 2024 based off last year's report dates. Learn more on CVAC's earnings history.

Did CureVac beat their earnings estimates last quarter?

In the previous quarter, CureVac (NASDAQ:CVAC) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.26) by $0.02. Learn more on analysts' earnings estimate vs. CVAC's actual earnings.

How can I listen to CureVac's earnings conference call?

The conference call for CureVac's latest earnings report can be listened to online. Listen to Conference Call

How can I read CureVac's conference call transcript?

The conference call transcript for CureVac's latest earnings report can be read online. Read Transcript

How much revenue does CureVac generate each year?

CureVac (NASDAQ:CVAC) has a recorded annual revenue of $72.33 million.

How much profit does CureVac generate each year?

CureVac (NASDAQ:CVAC) has a recorded net income of -$262.38 million. CVAC has generated $0.00 earnings per share over the last four quarters.

What is CureVac's EPS forecast for next year?

CureVac's earnings are expected to grow from ($0.91) per share to ($0.76) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CVAC) was last updated on 2/21/2024 by MarketBeat.com Staff